Table 3 HIV, HR-HPV and risk of SIL
From: HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study
SIL absent N | SIL present N (%) | Adjusted OR* (95% CI) | |
|---|---|---|---|
HIV – HR-HPV- | 1 070 | 23 (2.1 %)) | Reference |
HIV+ HR-HPV- | 35 | 5 (12.5 %) | 6.5 (2.3 – 33.0) |
HIV- HR-HPV+ | 136 | 57 (29.5 %) | 19.6 (11.7 – 33.0) |
HIV+ HR-HPV+ | 20 | 18 (47.4 %) | 41.3 (18.8 – 90.5) |